Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,344 | -4,815 | 21,591 | 9,323 | 3,527 |
| Depreciation Amortization | 5,805 | 2,897 | 11,519 | 8,630 | 5,754 |
| Accounts receivable | 19,805 | 23,143 | -8,368 | 10,862 | 8,546 |
| Accounts payable and accrued liabilities | 6,611 | 2,075 | 449 | -1,379 | 1,355 |
| Other Working Capital | 11,446 | 10,677 | -17,854 | -10,353 | -9,126 |
| Other Operating Activity | -22,050 | -22,731 | 19,672 | -529 | -4,117 |
| Operating Cash Flow | $12,273 | $11,246 | $27,009 | $16,554 | $5,939 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | N/A | -140 | -95 | -68 |
| Purchase Of Investment | -44,892 | -24,974 | -23,813 | -12,511 | -10,543 |
| Sale Of Investment | 26,535 | 5,894 | 17,328 | 14,151 | 978 |
| Purchase Sale Intangibles | N/A | N/A | -12,500 | -12,500 | -12,500 |
| Other Investing Activity | 0 | 0 | -12,500 | -12,500 | -12,500 |
| Investing Cash Flow | $-18,377 | $-19,080 | $-19,125 | $-10,955 | $-22,133 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,110 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -222 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-11,332 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 86,676 | 86,676 | 78,792 | 78,792 | 78,792 |
| End Cash Position | 69,240 | 78,842 | 86,676 | 84,391 | 62,598 |
| Net Cash Flow | $-17,436 | $-7,834 | $7,884 | $5,599 | $-16,194 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,273 | 11,246 | 27,009 | 16,554 | 5,939 |
| Capital Expenditure | -20 | N/A | -140 | -95 | -68 |
| Free Cash Flow | 12,253 | 11,246 | 26,869 | 16,459 | 5,871 |